To Evaluate the Physical Effects of Systane(R) Lubricant Eye Drops Compared to Refresh Tears(R) Lubricant Eye Drops
This study has been completed.
Sponsor:
Alcon Research
Information provided by (Responsible Party):
Alcon Research
ClinicalTrials.gov Identifier:
NCT01160133
First received: July 9, 2010
Last updated: April 7, 2012
Last verified: January 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a multi-site, randomized, investigator-masked study to evaluate the physical effects of Systane(R) versus Refresh Tears(R) in subjects with moderate to severe dry eye. It is a 6-week, perspective, randomized, active-controlled, investigator-masked, parallel group study.
| Condition | Intervention |
|---|---|
|
Dry Eye |
Other: Systane Other: Refresh Tears |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator) Primary Purpose: Treatment |
Resource links provided by NLM:
Genetics Home Reference related topics:
keratitis-ichthyosis-deafness syndrome
Drug Information available for:
Tetrahydrozoline hydrochloride
Carboxymethylcellulose sodium
Boric acid
Croscarmellose sodium
U.S. FDA Resources
Further study details as provided by Alcon Research:
Primary Outcome Measures:
- To evaluate physical effects of Systane and Refresh Tears in subjects to moderate to severe dry eye. [ Time Frame: Baseline to visit 3 (Day 42) ] [ Designated as safety issue: Yes ]This is a descriptive study in which changes from baseline in Tear Break up Time, corneal staining, and the Ocular Symptoms Questionnaire will be evaluated by treatment group at every visit. The outcome of the IDEEL questionnaire at Visit 3 will be compared to Visit 1 by treatment group; the results of treatment satisfaction questionnaires will be tabulated by treatment at Visit 3.
| Enrollment: | 78 |
| Study Start Date: | July 2010 |
| Study Completion Date: | June 2011 |
| Primary Completion Date: | June 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Systane
Systane Lubricant Eye Drops
|
Other: Systane
Systane Lubricant Eye Drops (1-2 drops in each eye, four times per day)
|
|
Experimental: Refresh Tears
Refresh Tears Lubricant Eye Drops
|
Other: Refresh Tears
Refresh Tears Lubricant Eye Drops (1-2 drops in each eye, four times per day)
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Patient must be 18 years of age or older of any sex and any race, with a score of at least 2 (some of the time) on the subject-assessed Symptom Eligibility question.
- A sodium fluorescein corneal staining sum of ≥ 3 in either eye.
- A best-corrected visual acuity of 0.6 logMAR or better in each eye as assessed using an ETDRS chart.
Exclusion Criteria:
- A history or evidence of ocular or intraocular surgery in either eye within the past 6 months.
- Lasik patients can be included if lasik surgery was greater than 6 months prior to the initiation of the study.
- A history of intolerance or hypersensitivity to any component of the study medications.
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT01160133 History of Changes |
| Other Study ID Numbers: | SMA-09-67 |
| Study First Received: | July 9, 2010 |
| Last Updated: | April 7, 2012 |
| Health Authority: | India: Institutional Review Board |
Keywords provided by Alcon Research:
|
Systane Refresh Tears Dry Eye Moderate to Severe Dry Eye |
Additional relevant MeSH terms:
|
Keratoconjunctivitis Sicca Dry Eye Syndromes Keratoconjunctivitis Conjunctivitis Conjunctival Diseases Eye Diseases Keratitis Corneal Diseases Lacrimal Apparatus Diseases Tetrahydrozoline Carboxymethylcellulose Sodium Nasal Decongestants |
Vasoconstrictor Agents Cardiovascular Agents Therapeutic Uses Pharmacologic Actions Respiratory System Agents Sympathomimetics Autonomic Agents Peripheral Nervous System Agents Physiological Effects of Drugs Laxatives Gastrointestinal Agents |
ClinicalTrials.gov processed this record on May 21, 2013